STAT5 activation promotes progression and chemotherapy resistance in early T-cell precursor acute lymphoblastic leukemia.
Tremblay CS, Saw J, Boyle JA, Haigh K, Litalien V, McCalmont H, Evans K, Lock RB, Jane SM, Haigh JJ, et al. Blood. 2023 Jul 20; 142(3):274-289.